Facebook
Twitter
LinkedIn
Forward
ASTCT/EBMT 6th International Conference on Relapse After Transplant and Cellular Therapy (HSCT²)
Universal City, CA US
November 10, 2023 to November 11, 2023
Hematopoietic stem cell transplantation (HSCT) and cellular therapy are life-saving treatment options for many hematologic malignancies and some solid tumors. Relapse and disease progression are the leading causes of treatment failure for most hematologic malignancies both allogeneic and autologous HSCT. During the last five years, significant advances have been made in the understanding of the biology of relapse, including understanding the role of human leukocyte antigens (HLA) loss, clonal evolution, and T-cell exhaustion. Experts agree healthcare professionals must stay current on research and changes in this field. Remaining informed on best practices, the latest treatment options, preventive strategies, and management of toxicities in relapse after HSCT and cellular therapy will aid healthcare teams and researchers in improving patient outcomes.
This activity will provide a forum for participants to learn about and discuss the latest development and therapeutic approaches for preventing and treating relapse after HSCT and cellular therapy. It will include presentations, panel discussions, and Q&A on gaps in knowledge, current research, and topics for future study relative to the biology, natural history, prevention, and treatment of relapse following allogeneic HSCT and cellular therapy.
Target Audience
This activity is designed for hematologists and oncologists, hematopoietic stem and immune cell translational and basic scientists, hematopathologists, physicians-in-training, advanced practice providers, pharmacists, oncology nurses, and other healthcare professionals dedicated to providing the highest level of care in HSCT and cellular therapy for hematologic malignancies.
Learning Objectives
After this activity, participants will be able to:
- State the basic mechanisms of relapse after transplant and cellular therapies;
- Recognize risk factors for relapse after transplant and cellular therapies;
- Recognize the importance of clinical trials in this patient population;
- Identify strategies to prevent relapse after transplant and cellular therapies;
- Identify treatment strategies that can be used to treat patients who have relapsed after transplant.
You may also be interested in
Sheraton Universal Hotel
333 Universal Hollywood Drive
Universal City, CA
91608
United States
SPECIAL HOTEL RATES ARE AVAILABLE FOR PARTICIPANTS!
A block of rooms has been held at the Sheraton Universal Hotel.
Nestled below the Hollywood Hills, the AAA 4-diamond Sheraton Universal Hotel is just steps away from Universal Studios Hollywood and CityWalk. A short walk to Metro’s red line, easily reach L.A. attractions such as the Walk of Fame, the Hollywood Bowl, and Grauman's Chinese Theatre. Guest rooms pay homage to their Hollywood roots and offer a modern, sleek, minimalist ambiance. Recharge with the Sheraton Signature Sleep Experience®, free Wi-Fi*, smart T.V.s, and floor-to-ceiling windows with stunning views of the San Fernando Valley and Hollywood Hills. Enjoy breakfast at The California's, ride our free shuttle to Universal Studios Hollywood theme park; unwind at the pool and seasonal poolside lounge and end your day at In the Mix, our sleek hotel bar serving an extensive selection of beverages. Guests will be dazzled with a 270° view of Hollywood from the 20-foot windows of the rooftop Starview Room.
Whether it is a business trip or a family vacation, the Sheraton Universal Hotel experience awaits you. Click here to secure your discounted rate. Housing will open in June 2023.
ACCESSIBILITY The ASTCT and EBMT are committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact Anna Hawkshead at 312-673–4965 or via email at ahawkshead@astct.org.
ASTCT and EBMT reserve the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, ASTCT and EBMT are not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
Nestled below the Hollywood Hills, the AAA 4-diamond Sheraton Universal Hotel is just steps away from Universal Studios Hollywood and CityWalk. A short walk to Metro’s red line, easily reach L.A. attractions such as the Walk of Fame, the Hollywood Bowl, and Grauman's Chinese Theatre. Guest rooms pay homage to their Hollywood roots and offer a modern, sleek, minimalist ambiance. Recharge with the Sheraton Signature Sleep Experience®, free Wi-Fi*, smart T.V.s, and floor-to-ceiling windows with stunning views of the San Fernando Valley and Hollywood Hills. Enjoy breakfast at The California's, ride our free shuttle to Universal Studios Hollywood theme park; unwind at the pool and seasonal poolside lounge and end your day at In the Mix, our sleek hotel bar serving an extensive selection of beverages. Guests will be dazzled with a 270° view of Hollywood from the 20-foot windows of the rooftop Starview Room.
Whether it is a business trip or a family vacation, the Sheraton Universal Hotel experience awaits you. Click here to secure your discounted rate. Housing will open in June 2023.
ACCESSIBILITY The ASTCT and EBMT are committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact Anna Hawkshead at 312-673–4965 or via email at ahawkshead@astct.org.
ASTCT and EBMT reserve the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, ASTCT and EBMT are not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
PLANNING COMMITTEE
Michael Bishop, MDProfessor of Medicine
Director, Hematopoietic Stem Cell Transplantation Program
University of Chicago
Sergio Giralt, MDDeputy Division Head, Division of Hematologic Malignancies
Melvin Berlin Family Chair in Multiple Myeloma
Memorial Sloan Kettering Cancer Center
Alan Wayne, MDDirector, Cancer and Blood Disease Institute
Head, Division of Hematology-Oncology
Attending Physician, Hematology-Oncology
Alfred E. Mann Family Foundation Chair in Cancer Research
Professor of Pediatrics and Medicine
University of Southern California
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 12.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professions Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Please Note: The credit claiming process will close three months after the conference end date. Requests to claim credit after three months will be subject to additional fees.
EXHIBIT OPPORTUNITIES AVAILABLE!
This conference offers a tremendous opportunity to highlight your company's products, services, and achievements in front of a wide array of key decision-makers. Increase your company profile by participating as an exhibitor at this exciting event.
We are pleased to provide opportunities for organizations to advertise their products and services to conference participants. Whether you are connecting with physicians during scheduled breaks, leading a special sponsored session about your products, or gaining brand recognition for your company through program acknowledgments and other sponsorship opportunities, your message will reach physicians, nurses, and other healthcare professionals.
Download the prospectus 
here or contact ASTCT at adahl@astct.org or (312) 673-4833. We hope to see you there!
here or contact ASTCT at adahl@astct.org or (312) 673-4833. We hope to see you there!
Registration: Registration is coming soon! For more information, click below.
Claiming Credit: Enter the access code to unlock the credit-claiming process.
Please Note: The credit claiming process will close three months after the activity ends. Requests for certificates after three months will be subject to additional fees.
Please Note: The credit claiming process will close three months after the activity ends. Requests for certificates after three months will be subject to additional fees.
Please login or create an account to proceed.